| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 291 | 2024 | 1740 | 23.720 |
Why?
|
| Protozoan Proteins | 190 | 2024 | 846 | 20.930 |
Why?
|
| Erythrocytes | 132 | 2023 | 2410 | 11.750 |
Why?
|
| Antigens, Protozoan | 77 | 2023 | 316 | 10.460 |
Why?
|
| Malaria, Falciparum | 97 | 2024 | 1076 | 9.930 |
Why?
|
| Antimalarials | 56 | 2024 | 907 | 5.090 |
Why?
|
| Merozoites | 35 | 2023 | 61 | 4.690 |
Why?
|
| Malaria Vaccines | 28 | 2022 | 163 | 4.210 |
Why?
|
| Malaria | 39 | 2024 | 1226 | 4.150 |
Why?
|
| Antibodies, Protozoan | 33 | 2022 | 251 | 3.670 |
Why?
|
| Aspartic Acid Endopeptidases | 13 | 2022 | 311 | 3.670 |
Why?
|
| Carrier Proteins | 33 | 2024 | 4935 | 2.710 |
Why?
|
| Genes, Protozoan | 43 | 2013 | 170 | 2.540 |
Why?
|
| Plasmodium | 16 | 2021 | 246 | 2.370 |
Why?
|
| Host-Parasite Interactions | 14 | 2021 | 300 | 2.360 |
Why?
|
| Vacuoles | 25 | 2022 | 228 | 2.250 |
Why?
|
| Membrane Proteins | 49 | 2019 | 7847 | 2.150 |
Why?
|
| Erythrocyte Membrane | 22 | 2022 | 439 | 2.100 |
Why?
|
| Virulence Factors | 10 | 2018 | 513 | 1.800 |
Why?
|
| Endocytosis | 8 | 2020 | 955 | 1.690 |
Why?
|
| Drug Resistance | 50 | 2024 | 1594 | 1.620 |
Why?
|
| Protein Transport | 34 | 2022 | 1966 | 1.510 |
Why?
|
| Toxoplasma | 10 | 2019 | 157 | 1.410 |
Why?
|
| Chloroquine | 28 | 2019 | 274 | 1.410 |
Why?
|
| Cell Adhesion | 24 | 2017 | 3088 | 1.250 |
Why?
|
| Parasites | 9 | 2022 | 160 | 1.220 |
Why?
|
| Merozoite Surface Protein 1 | 7 | 2017 | 37 | 1.200 |
Why?
|
| DNA, Protozoan | 30 | 2012 | 228 | 1.190 |
Why?
|
| Animals | 266 | 2024 | 168201 | 1.140 |
Why?
|
| Antigenic Variation | 10 | 2012 | 118 | 1.120 |
Why?
|
| Folic Acid Antagonists | 8 | 2023 | 75 | 1.050 |
Why?
|
| Artemisinins | 5 | 2020 | 218 | 1.030 |
Why?
|
| Blood Group Antigens | 3 | 2022 | 182 | 1.020 |
Why?
|
| Protein Sorting Signals | 9 | 2010 | 278 | 0.990 |
Why?
|
| Dihydropteroate Synthase | 6 | 2003 | 27 | 0.960 |
Why?
|
| Genome, Protozoan | 12 | 2010 | 152 | 0.960 |
Why?
|
| ATP-Binding Cassette Transporters | 11 | 2005 | 563 | 0.950 |
Why?
|
| Multiprotein Complexes | 5 | 2018 | 1118 | 0.920 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 11 | 2006 | 132 | 0.920 |
Why?
|
| Plasmodium vivax | 8 | 2021 | 202 | 0.920 |
Why?
|
| Receptors, Complement | 4 | 2015 | 253 | 0.910 |
Why?
|
| Protein Binding | 29 | 2018 | 9345 | 0.900 |
Why?
|
| Plasmodium berghei | 6 | 2020 | 159 | 0.870 |
Why?
|
| Mefloquine | 11 | 2017 | 55 | 0.850 |
Why?
|
| Molecular Sequence Data | 73 | 2015 | 17629 | 0.850 |
Why?
|
| Sporozoites | 7 | 2024 | 82 | 0.840 |
Why?
|
| Life Cycle Stages | 12 | 2024 | 160 | 0.830 |
Why?
|
| Virulence | 12 | 2012 | 1299 | 0.830 |
Why?
|
| Reticulocytes | 5 | 2020 | 289 | 0.810 |
Why?
|
| Amino Acid Sequence | 65 | 2015 | 13441 | 0.810 |
Why?
|
| Recombination, Genetic | 11 | 2014 | 1519 | 0.760 |
Why?
|
| Apicomplexa | 4 | 2014 | 9 | 0.730 |
Why?
|
| Receptors, Cell Surface | 12 | 2019 | 2802 | 0.720 |
Why?
|
| Endoplasmic Reticulum | 9 | 2020 | 1132 | 0.690 |
Why?
|
| Transfection | 24 | 2010 | 5766 | 0.690 |
Why?
|
| Green Fluorescent Proteins | 21 | 2015 | 2063 | 0.670 |
Why?
|
| Protein Structure, Tertiary | 19 | 2015 | 3792 | 0.640 |
Why?
|
| Gene Silencing | 7 | 2011 | 1503 | 0.630 |
Why?
|
| Protease Inhibitors | 4 | 2022 | 753 | 0.630 |
Why?
|
| Recombinant Fusion Proteins | 25 | 2013 | 3730 | 0.600 |
Why?
|
| Cryoelectron Microscopy | 2 | 2018 | 650 | 0.590 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2012 | 682 | 0.590 |
Why?
|
| Amino Acid Motifs | 5 | 2016 | 927 | 0.570 |
Why?
|
| Antibodies, Neutralizing | 2 | 2019 | 1936 | 0.550 |
Why?
|
| Multigene Family | 16 | 2009 | 1076 | 0.540 |
Why?
|
| Gene Deletion | 12 | 2014 | 2661 | 0.530 |
Why?
|
| Models, Molecular | 9 | 2019 | 5433 | 0.530 |
Why?
|
| N-Acetylneuraminic Acid | 6 | 2010 | 174 | 0.530 |
Why?
|
| Anopheles | 5 | 2014 | 192 | 0.530 |
Why?
|
| Actins | 6 | 2015 | 2050 | 0.530 |
Why?
|
| Plasmids | 15 | 2013 | 2265 | 0.520 |
Why?
|
| Sequence Homology, Amino Acid | 23 | 2015 | 2747 | 0.520 |
Why?
|
| Pyrimethamine | 12 | 2008 | 94 | 0.520 |
Why?
|
| Drug Resistance, Multiple | 6 | 2005 | 255 | 0.510 |
Why?
|
| Parasitemia | 7 | 2022 | 165 | 0.490 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2016 | 201 | 0.490 |
Why?
|
| Humans | 207 | 2024 | 760617 | 0.490 |
Why?
|
| Peptidomimetics | 3 | 2022 | 31 | 0.490 |
Why?
|
| Gene Expression Regulation | 15 | 2012 | 11874 | 0.480 |
Why?
|
| Phosphotransferases | 1 | 2015 | 303 | 0.480 |
Why?
|
| Restriction Mapping | 10 | 1999 | 851 | 0.470 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2011 | 451 | 0.470 |
Why?
|
| Organelles | 10 | 2009 | 266 | 0.440 |
Why?
|
| Base Sequence | 48 | 2013 | 12421 | 0.440 |
Why?
|
| Culicidae | 4 | 2019 | 108 | 0.430 |
Why?
|
| Recombinant Proteins | 19 | 2017 | 6520 | 0.430 |
Why?
|
| Cell Membrane | 10 | 2019 | 3680 | 0.430 |
Why?
|
| Rabbits | 13 | 2015 | 4770 | 0.430 |
Why?
|
| Malaria, Vivax | 3 | 2021 | 166 | 0.430 |
Why?
|
| Gene Knockout Techniques | 5 | 2014 | 801 | 0.420 |
Why?
|
| Peptides | 12 | 2015 | 4354 | 0.420 |
Why?
|
| Thymidylate Synthase | 5 | 1996 | 74 | 0.410 |
Why?
|
| Gene Expression | 14 | 2014 | 7568 | 0.400 |
Why?
|
| Ligands | 12 | 2015 | 3268 | 0.400 |
Why?
|
| Chromosomes | 11 | 2009 | 578 | 0.400 |
Why?
|
| Promoter Regions, Genetic | 8 | 2012 | 5780 | 0.390 |
Why?
|
| Gene Amplification | 11 | 1996 | 1087 | 0.390 |
Why?
|
| Host-Pathogen Interactions | 3 | 2017 | 1454 | 0.390 |
Why?
|
| Molecular Motor Proteins | 3 | 2006 | 106 | 0.390 |
Why?
|
| Conserved Sequence | 9 | 2013 | 1162 | 0.380 |
Why?
|
| Antiparasitic Agents | 2 | 2019 | 42 | 0.380 |
Why?
|
| Nuclear Proteins | 4 | 2011 | 5789 | 0.370 |
Why?
|
| Selection, Genetic | 4 | 2010 | 868 | 0.370 |
Why?
|
| Peroxiredoxins | 1 | 2011 | 51 | 0.360 |
Why?
|
| Genetics, Microbial | 1 | 2010 | 53 | 0.360 |
Why?
|
| Parasitology | 1 | 2010 | 28 | 0.360 |
Why?
|
| Structure-Activity Relationship | 11 | 2024 | 3074 | 0.350 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2010 | 175 | 0.350 |
Why?
|
| Crystallography, X-Ray | 4 | 2017 | 1989 | 0.350 |
Why?
|
| Polymorphism, Genetic | 13 | 2012 | 4242 | 0.340 |
Why?
|
| Cloning, Molecular | 27 | 2004 | 4172 | 0.340 |
Why?
|
| Epigenesis, Genetic | 5 | 2012 | 3794 | 0.340 |
Why?
|
| Adenosine Triphosphatases | 4 | 1995 | 835 | 0.340 |
Why?
|
| Cysteine | 3 | 2023 | 891 | 0.340 |
Why?
|
| Microscopy, Fluorescence | 16 | 2019 | 2639 | 0.340 |
Why?
|
| Immunoblotting | 9 | 2015 | 1646 | 0.330 |
Why?
|
| Hepatocytes | 4 | 2024 | 1231 | 0.330 |
Why?
|
| Epidermal Growth Factor | 2 | 2011 | 699 | 0.320 |
Why?
|
| Parasitic Sensitivity Tests | 9 | 2024 | 89 | 0.320 |
Why?
|
| Sulfadoxine | 6 | 2008 | 46 | 0.320 |
Why?
|
| Cytosine Deaminase | 2 | 2006 | 66 | 0.320 |
Why?
|
| Genes, MDR | 2 | 2005 | 36 | 0.310 |
Why?
|
| Membrane Glycoproteins | 8 | 2009 | 3688 | 0.310 |
Why?
|
| Substrate Specificity | 3 | 2022 | 1790 | 0.310 |
Why?
|
| Cell Compartmentation | 4 | 2012 | 384 | 0.310 |
Why?
|
| Quinazolines | 3 | 2021 | 1371 | 0.310 |
Why?
|
| Transcription, Genetic | 19 | 2011 | 7583 | 0.310 |
Why?
|
| Antigens, Helminth | 5 | 2004 | 68 | 0.300 |
Why?
|
| Models, Biological | 18 | 2016 | 9461 | 0.300 |
Why?
|
| Integrases | 1 | 2010 | 518 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 21 | 2012 | 6074 | 0.300 |
Why?
|
| Immune Evasion | 3 | 2017 | 363 | 0.290 |
Why?
|
| Fetal Proteins | 1 | 2008 | 98 | 0.290 |
Why?
|
| Cytochromes b | 2 | 2024 | 35 | 0.290 |
Why?
|
| Cell Division | 3 | 2012 | 4457 | 0.290 |
Why?
|
| Alleles | 11 | 2012 | 6861 | 0.290 |
Why?
|
| Chromatin | 2 | 2011 | 2955 | 0.290 |
Why?
|
| Cytoplasm | 6 | 2009 | 1503 | 0.290 |
Why?
|
| Transgenes | 7 | 2007 | 1008 | 0.280 |
Why?
|
| Intracellular Membranes | 5 | 2013 | 389 | 0.280 |
Why?
|
| Cellular Structures | 1 | 2006 | 9 | 0.280 |
Why?
|
| Chromosome Mapping | 20 | 2002 | 4611 | 0.270 |
Why?
|
| Pentosyltransferases | 1 | 2006 | 62 | 0.270 |
Why?
|
| Gene Targeting | 7 | 2009 | 837 | 0.270 |
Why?
|
| Cell Nucleus | 6 | 2009 | 2894 | 0.270 |
Why?
|
| Plasmodium knowlesi | 2 | 2021 | 23 | 0.270 |
Why?
|
| Sirtuins | 1 | 2009 | 319 | 0.260 |
Why?
|
| Trypsin | 3 | 2005 | 495 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 3 | 2009 | 1602 | 0.260 |
Why?
|
| Animals, Genetically Modified | 8 | 2012 | 1557 | 0.260 |
Why?
|
| Cell Communication | 1 | 2013 | 1654 | 0.260 |
Why?
|
| Genes | 9 | 1991 | 1823 | 0.260 |
Why?
|
| Acetamides | 2 | 2024 | 256 | 0.250 |
Why?
|
| Protozoan Infections | 2 | 2004 | 38 | 0.250 |
Why?
|
| Immunoglobulin G | 10 | 2019 | 4533 | 0.250 |
Why?
|
| Sesquiterpenes | 3 | 2003 | 176 | 0.250 |
Why?
|
| Golgi Apparatus | 5 | 2008 | 404 | 0.250 |
Why?
|
| Molecular Structure | 6 | 2024 | 1878 | 0.250 |
Why?
|
| Biological Transport | 7 | 2018 | 2089 | 0.240 |
Why?
|
| Sex Determination Processes | 1 | 2005 | 60 | 0.240 |
Why?
|
| Aniline Compounds | 2 | 2021 | 1068 | 0.240 |
Why?
|
| Opsonin Proteins | 2 | 2016 | 144 | 0.240 |
Why?
|
| Taenia | 4 | 1998 | 17 | 0.240 |
Why?
|
| Complement Activation | 2 | 2017 | 445 | 0.230 |
Why?
|
| Chromosomes, Artificial, Yeast | 4 | 1997 | 113 | 0.230 |
Why?
|
| Genome | 3 | 2005 | 1737 | 0.230 |
Why?
|
| Cytosol | 5 | 2010 | 886 | 0.230 |
Why?
|
| Mice | 28 | 2024 | 81368 | 0.230 |
Why?
|
| Papua New Guinea | 6 | 2019 | 46 | 0.220 |
Why?
|
| Binding Sites | 10 | 2018 | 6051 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 13 | 2015 | 2467 | 0.220 |
Why?
|
| Parasitic Diseases | 1 | 2003 | 76 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2019 | 485 | 0.220 |
Why?
|
| Calcium | 7 | 2016 | 5717 | 0.210 |
Why?
|
| Mutation | 21 | 2024 | 30016 | 0.210 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 10 | 2002 | 783 | 0.210 |
Why?
|
| Neuraminidase | 5 | 2011 | 195 | 0.210 |
Why?
|
| Telomere | 6 | 2009 | 940 | 0.210 |
Why?
|
| Vaccines, Combined | 1 | 2022 | 70 | 0.210 |
Why?
|
| Liver | 6 | 2024 | 7512 | 0.210 |
Why?
|
| Quinazolinones | 1 | 2024 | 221 | 0.210 |
Why?
|
| Immunotherapy, Active | 1 | 2002 | 58 | 0.210 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 1130 | 0.210 |
Why?
|
| Heterochromatin | 1 | 2005 | 291 | 0.200 |
Why?
|
| Triazines | 4 | 2006 | 311 | 0.200 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2020 | 465 | 0.200 |
Why?
|
| Vaccination | 3 | 2017 | 3370 | 0.200 |
Why?
|
| Microscopy, Immunoelectron | 6 | 2011 | 317 | 0.200 |
Why?
|
| Blood | 2 | 2019 | 596 | 0.200 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 2017 | 189 | 0.200 |
Why?
|
| Plasmodium chabaudi | 2 | 2001 | 19 | 0.200 |
Why?
|
| Brefeldin A | 4 | 2012 | 68 | 0.200 |
Why?
|
| Tight Junctions | 4 | 2015 | 324 | 0.200 |
Why?
|
| DNA Primers | 12 | 2012 | 2817 | 0.200 |
Why?
|
| Plastids | 4 | 2010 | 8 | 0.200 |
Why?
|
| RNA, Protozoan | 5 | 2009 | 45 | 0.190 |
Why?
|
| Pseudogenes | 1 | 2001 | 104 | 0.190 |
Why?
|
| Immunoprecipitation | 5 | 2015 | 876 | 0.190 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 2005 | 1738 | 0.190 |
Why?
|
| Babesia bovis | 2 | 2019 | 4 | 0.180 |
Why?
|
| Transport Vesicles | 2 | 2014 | 81 | 0.180 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2005 | 634 | 0.180 |
Why?
|
| Antigens, Surface | 8 | 2008 | 1605 | 0.180 |
Why?
|
| Oxidative Stress | 2 | 2011 | 3113 | 0.180 |
Why?
|
| Luminescent Proteins | 8 | 2004 | 836 | 0.180 |
Why?
|
| Quinine | 7 | 2001 | 51 | 0.170 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2021 | 140 | 0.170 |
Why?
|
| Gametogenesis | 1 | 2019 | 26 | 0.170 |
Why?
|
| Fosfomycin | 1 | 2019 | 24 | 0.170 |
Why?
|
| Carbon | 2 | 2022 | 665 | 0.170 |
Why?
|
| Contig Mapping | 1 | 1999 | 54 | 0.170 |
Why?
|
| Signal Transduction | 8 | 2017 | 23416 | 0.170 |
Why?
|
| Genes, Helminth | 3 | 2001 | 146 | 0.170 |
Why?
|
| Quinolones | 1 | 2023 | 378 | 0.170 |
Why?
|
| Kinetics | 6 | 2022 | 6370 | 0.170 |
Why?
|
| Protein Conformation | 4 | 2017 | 3965 | 0.160 |
Why?
|
| Oligopeptides | 2 | 2015 | 1185 | 0.160 |
Why?
|
| Cryptosporidium parvum | 1 | 2019 | 35 | 0.160 |
Why?
|
| Epitopes | 3 | 2022 | 2501 | 0.160 |
Why?
|
| Species Specificity | 5 | 2013 | 2411 | 0.160 |
Why?
|
| Vaccines, Synthetic | 2 | 2016 | 612 | 0.160 |
Why?
|
| Cells, Cultured | 9 | 2015 | 18937 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2019 | 1971 | 0.160 |
Why?
|
| Blotting, Southern | 8 | 2004 | 777 | 0.150 |
Why?
|
| Transaminases | 1 | 1999 | 199 | 0.150 |
Why?
|
| Subcellular Fractions | 3 | 2013 | 531 | 0.150 |
Why?
|
| Multienzyme Complexes | 4 | 2004 | 666 | 0.150 |
Why?
|
| Phosphorylation | 6 | 2019 | 8311 | 0.150 |
Why?
|
| Gene Rearrangement | 2 | 1996 | 1125 | 0.150 |
Why?
|
| Point Mutation | 3 | 2019 | 1595 | 0.150 |
Why?
|
| Purines | 1 | 2021 | 606 | 0.150 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 412 | 0.150 |
Why?
|
| Isoquinolines | 1 | 2019 | 352 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2009 | 3777 | 0.150 |
Why?
|
| Blood Proteins | 3 | 1997 | 1172 | 0.150 |
Why?
|
| Amino Acids | 4 | 2022 | 1717 | 0.150 |
Why?
|
| Sequence Alignment | 9 | 2009 | 2178 | 0.140 |
Why?
|
| Computational Biology | 6 | 2013 | 3509 | 0.140 |
Why?
|
| Surface Plasmon Resonance | 2 | 2015 | 269 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 11 | 2013 | 4739 | 0.140 |
Why?
|
| DNA, Recombinant | 5 | 2002 | 455 | 0.140 |
Why?
|
| Membrane Transport Proteins | 3 | 2012 | 1034 | 0.140 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2010 | 695 | 0.140 |
Why?
|
| Protein Biosynthesis | 3 | 2017 | 2100 | 0.140 |
Why?
|
| Bioreactors | 1 | 2018 | 246 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2011 | 4570 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2011 | 398 | 0.140 |
Why?
|
| Cytoskeleton | 4 | 2011 | 1170 | 0.140 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2017 | 97 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 477 | 0.140 |
Why?
|
| Phenanthrenes | 4 | 2013 | 66 | 0.130 |
Why?
|
| Chondroitin Sulfates | 4 | 2007 | 174 | 0.130 |
Why?
|
| Blotting, Western | 9 | 2015 | 5034 | 0.130 |
Why?
|
| Babesia | 3 | 1987 | 29 | 0.130 |
Why?
|
| Escherichia coli | 11 | 2016 | 4209 | 0.130 |
Why?
|
| Viscosity | 1 | 2017 | 336 | 0.130 |
Why?
|
| Pyrazoles | 2 | 2024 | 2008 | 0.130 |
Why?
|
| Cations, Divalent | 1 | 2016 | 168 | 0.130 |
Why?
|
| Elasticity | 2 | 2017 | 655 | 0.130 |
Why?
|
| Complement Factor H | 1 | 2015 | 110 | 0.130 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 3 | 2003 | 221 | 0.130 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1995 | 122 | 0.120 |
Why?
|
| Exocytosis | 1 | 2016 | 320 | 0.120 |
Why?
|
| Proteome | 1 | 2005 | 1857 | 0.120 |
Why?
|
| Cell Line | 7 | 2019 | 15576 | 0.120 |
Why?
|
| Sulfones | 1 | 1997 | 447 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 933 | 0.120 |
Why?
|
| Aspartic Acid Proteases | 1 | 2014 | 9 | 0.120 |
Why?
|
| Flucytosine | 2 | 2006 | 33 | 0.120 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 724 | 0.120 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 2001 | 1058 | 0.120 |
Why?
|
| Genetic Vectors | 6 | 2005 | 3392 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 561 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 392 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2020 | 1540 | 0.110 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 5 | 2002 | 141 | 0.110 |
Why?
|
| Vaccines, Attenuated | 4 | 2021 | 315 | 0.110 |
Why?
|
| Centromere | 2 | 2012 | 212 | 0.110 |
Why?
|
| Verapamil | 5 | 2000 | 242 | 0.110 |
Why?
|
| Plasmodium yoelii | 3 | 2010 | 41 | 0.110 |
Why?
|
| Schizonts | 2 | 2012 | 22 | 0.110 |
Why?
|
| Phagocytosis | 5 | 2016 | 1526 | 0.110 |
Why?
|
| Carbamates | 1 | 2015 | 191 | 0.110 |
Why?
|
| Evolution, Molecular | 3 | 2008 | 1880 | 0.110 |
Why?
|
| Sequence Tagged Sites | 3 | 1999 | 96 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2020 | 2674 | 0.110 |
Why?
|
| Trophozoites | 1 | 2013 | 12 | 0.110 |
Why?
|
| Acetyl Coenzyme A | 1 | 2013 | 74 | 0.110 |
Why?
|
| Protein Multimerization | 2 | 2016 | 982 | 0.110 |
Why?
|
| Ribosomes | 1 | 2017 | 500 | 0.110 |
Why?
|
| Receptors, Complement 3b | 1 | 2013 | 135 | 0.110 |
Why?
|
| Electron Microscope Tomography | 1 | 2013 | 17 | 0.110 |
Why?
|
| Mutagenesis | 4 | 2013 | 1230 | 0.110 |
Why?
|
| Echinococcus | 2 | 2004 | 14 | 0.110 |
Why?
|
| Indonesia | 3 | 2021 | 128 | 0.110 |
Why?
|
| Chymotrypsin | 2 | 2003 | 138 | 0.110 |
Why?
|
| Glycolipids | 1 | 2014 | 206 | 0.110 |
Why?
|
| Inositol | 1 | 2014 | 215 | 0.110 |
Why?
|
| Amodiaquine | 3 | 2004 | 58 | 0.110 |
Why?
|
| Enzyme Inhibitors | 3 | 2019 | 3705 | 0.100 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 172 | 0.100 |
Why?
|
| Protein Unfolding | 1 | 2013 | 56 | 0.100 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1992 | 69 | 0.100 |
Why?
|
| Rats | 4 | 2024 | 23717 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2014 | 489 | 0.100 |
Why?
|
| Epitope Mapping | 1 | 2013 | 297 | 0.100 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 1994 | 195 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2024 | 10754 | 0.100 |
Why?
|
| Protein Structure, Secondary | 2 | 2012 | 1229 | 0.100 |
Why?
|
| Pyridines | 1 | 2024 | 2874 | 0.100 |
Why?
|
| Duffy Blood-Group System | 1 | 2012 | 58 | 0.100 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 469 | 0.100 |
Why?
|
| Helminth Proteins | 2 | 2004 | 172 | 0.100 |
Why?
|
| Cell Shape | 2 | 2015 | 369 | 0.100 |
Why?
|
| Fructose-Bisphosphate Aldolase | 2 | 2015 | 48 | 0.100 |
Why?
|
| Erythropoietin | 1 | 1996 | 719 | 0.100 |
Why?
|
| Molecular Weight | 7 | 2004 | 2185 | 0.100 |
Why?
|
| Fatty Acids | 4 | 2013 | 1808 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1608 | 0.100 |
Why?
|
| Pregnancy Complications, Parasitic | 2 | 2015 | 61 | 0.100 |
Why?
|
| Antibody Formation | 1 | 2016 | 1390 | 0.090 |
Why?
|
| Glutaredoxins | 1 | 2011 | 32 | 0.090 |
Why?
|
| Toxoplasmosis | 1 | 2011 | 94 | 0.090 |
Why?
|
| Antibody Specificity | 4 | 2019 | 1058 | 0.090 |
Why?
|
| Drosophila | 1 | 2018 | 1494 | 0.090 |
Why?
|
| Histones | 2 | 2012 | 2577 | 0.090 |
Why?
|
| Kenya | 4 | 2017 | 757 | 0.090 |
Why?
|
| Microscopy | 1 | 2016 | 905 | 0.090 |
Why?
|
| DNA | 13 | 2002 | 7196 | 0.090 |
Why?
|
| Asymptomatic Infections | 2 | 2022 | 131 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1662 | 0.090 |
Why?
|
| Child, Preschool | 16 | 2019 | 42188 | 0.090 |
Why?
|
| Calmodulin | 1 | 1991 | 218 | 0.090 |
Why?
|
| Protozoan Vaccines | 2 | 2000 | 13 | 0.090 |
Why?
|
| Vietnam | 3 | 2010 | 406 | 0.090 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2010 | 83 | 0.090 |
Why?
|
| Nucleotides | 1 | 1993 | 453 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2012 | 427 | 0.090 |
Why?
|
| Peptide Synthases | 1 | 2010 | 80 | 0.090 |
Why?
|
| Molecular Biology | 1 | 2014 | 575 | 0.090 |
Why?
|
| Communicable Disease Control | 1 | 2016 | 846 | 0.090 |
Why?
|
| Aminoquinolines | 2 | 2004 | 106 | 0.080 |
Why?
|
| Immunization | 2 | 2013 | 1217 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2011 | 202 | 0.080 |
Why?
|
| Insect Vectors | 1 | 2010 | 136 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1336 | 0.080 |
Why?
|
| DNA, Complementary | 6 | 2004 | 1989 | 0.080 |
Why?
|
| Antibodies | 1 | 2017 | 2414 | 0.080 |
Why?
|
| Open Reading Frames | 3 | 2006 | 813 | 0.080 |
Why?
|
| Phylogeny | 6 | 2012 | 2806 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4366 | 0.080 |
Why?
|
| Cattle Diseases | 2 | 2005 | 50 | 0.080 |
Why?
|
| Models, Theoretical | 2 | 2017 | 3567 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2013 | 2700 | 0.080 |
Why?
|
| Peptide Mapping | 1 | 2008 | 262 | 0.080 |
Why?
|
| Exosomes | 1 | 2013 | 424 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2014 | 1977 | 0.080 |
Why?
|
| Babesiosis | 3 | 2005 | 92 | 0.080 |
Why?
|
| Leucine Zippers | 1 | 2008 | 116 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2189 | 0.070 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 767 | 0.070 |
Why?
|
| RNA, Messenger | 10 | 2011 | 12758 | 0.070 |
Why?
|
| HIV Protease Inhibitors | 1 | 2010 | 432 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 3 | 2010 | 283 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9529 | 0.070 |
Why?
|
| Microtubules | 1 | 2013 | 1073 | 0.070 |
Why?
|
| Codon | 3 | 1998 | 600 | 0.070 |
Why?
|
| Eukaryota | 1 | 2008 | 102 | 0.070 |
Why?
|
| Blotting, Northern | 2 | 2007 | 1545 | 0.070 |
Why?
|
| Phenotype | 8 | 2009 | 16571 | 0.070 |
Why?
|
| Gene Dosage | 3 | 2013 | 1217 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2015 | 4058 | 0.070 |
Why?
|
| DNA, Helminth | 2 | 1997 | 35 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3800 | 0.070 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 1755 | 0.070 |
Why?
|
| Genes, Reporter | 4 | 2010 | 1525 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2011 | 2231 | 0.070 |
Why?
|
| Sequence Homology | 3 | 2002 | 196 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20074 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2015 | 5863 | 0.070 |
Why?
|
| Acetylation | 1 | 2008 | 1055 | 0.060 |
Why?
|
| Software | 2 | 2013 | 4431 | 0.060 |
Why?
|
| Antigens | 4 | 2003 | 1441 | 0.060 |
Why?
|
| Echinococcosis | 2 | 2004 | 31 | 0.060 |
Why?
|
| Sialic Acids | 1 | 2005 | 123 | 0.060 |
Why?
|
| Exons | 4 | 2008 | 2381 | 0.060 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 188 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2016 | 3769 | 0.060 |
Why?
|
| Thrombospondins | 1 | 2005 | 193 | 0.060 |
Why?
|
| Affinity Labels | 5 | 1997 | 107 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 206 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 3527 | 0.060 |
Why?
|
| Time Factors | 6 | 2013 | 39913 | 0.060 |
Why?
|
| Crossing Over, Genetic | 1 | 2004 | 92 | 0.060 |
Why?
|
| Protein Folding | 1 | 2008 | 870 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 2005 | 2561 | 0.060 |
Why?
|
| Biological Transport, Active | 2 | 2002 | 326 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2007 | 552 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2019 | 2625 | 0.060 |
Why?
|
| Microscopy, Confocal | 4 | 2007 | 1970 | 0.060 |
Why?
|
| Drug Combinations | 4 | 2008 | 2048 | 0.060 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 725 | 0.060 |
Why?
|
| Cell Movement | 2 | 2006 | 5200 | 0.060 |
Why?
|
| Genetic Variation | 5 | 2013 | 6561 | 0.060 |
Why?
|
| Proguanil | 2 | 1996 | 11 | 0.060 |
Why?
|
| Amino Acids, Acidic | 1 | 2003 | 3 | 0.060 |
Why?
|
| Databases, Protein | 1 | 2005 | 387 | 0.050 |
Why?
|
| Monocytes | 1 | 2012 | 2565 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 5 | 2015 | 6188 | 0.050 |
Why?
|
| Melanesia | 1 | 2002 | 13 | 0.050 |
Why?
|
| Complement C3b | 2 | 2013 | 97 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2024 | 4010 | 0.050 |
Why?
|
| Cyclopropanes | 1 | 2024 | 432 | 0.050 |
Why?
|
| Surface Properties | 1 | 2006 | 1161 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 983 | 0.050 |
Why?
|
| Movement | 2 | 2009 | 1476 | 0.050 |
Why?
|
| Child | 14 | 2017 | 80079 | 0.050 |
Why?
|
| Complement C4b | 2 | 2013 | 126 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2009 | 1409 | 0.050 |
Why?
|
| Solubility | 1 | 2024 | 1089 | 0.050 |
Why?
|
| Africa | 2 | 2001 | 710 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2006 | 2509 | 0.050 |
Why?
|
| Extrachromosomal Inheritance | 1 | 2002 | 18 | 0.050 |
Why?
|
| Genomics | 3 | 2009 | 5822 | 0.050 |
Why?
|
| Photobleaching | 1 | 2002 | 29 | 0.050 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2002 | 52 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 9172 | 0.050 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 555 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2004 | 2495 | 0.050 |
Why?
|
| 5' Untranslated Regions | 2 | 2001 | 253 | 0.050 |
Why?
|
| Nucleoside Deaminases | 1 | 2002 | 58 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2005 | 748 | 0.050 |
Why?
|
| Amination | 1 | 2021 | 18 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16967 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2328 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2003 | 315 | 0.050 |
Why?
|
| Amides | 1 | 2024 | 449 | 0.050 |
Why?
|
| Adolescent | 13 | 2017 | 88234 | 0.050 |
Why?
|
| Mitochondria | 2 | 2005 | 3619 | 0.050 |
Why?
|
| Vaccines | 3 | 2001 | 838 | 0.050 |
Why?
|
| Antimetabolites | 1 | 2002 | 129 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 286 | 0.050 |
Why?
|
| Photochemistry | 1 | 2001 | 239 | 0.050 |
Why?
|
| Cell-Free System | 2 | 2012 | 339 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2002 | 252 | 0.050 |
Why?
|
| Drug Resistance, Microbial | 2 | 2001 | 825 | 0.050 |
Why?
|
| Cell Death | 1 | 2006 | 1677 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2004 | 569 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2005 | 9417 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2002 | 234 | 0.050 |
Why?
|
| RNA Interference | 1 | 2009 | 2830 | 0.040 |
Why?
|
| Cross Reactions | 2 | 2012 | 816 | 0.040 |
Why?
|
| Secretory Pathway | 1 | 2020 | 53 | 0.040 |
Why?
|
| Sugar Acids | 1 | 2019 | 24 | 0.040 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 416 | 0.040 |
Why?
|
| Proteomics | 2 | 2023 | 3836 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1999 | 206 | 0.040 |
Why?
|
| Scintillation Counting | 1 | 1999 | 36 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3608 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2003 | 1739 | 0.040 |
Why?
|
| Developing Countries | 2 | 2002 | 2867 | 0.040 |
Why?
|
| Female | 21 | 2024 | 392148 | 0.040 |
Why?
|
| Organisms, Genetically Modified | 2 | 2012 | 63 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 1433 | 0.040 |
Why?
|
| Thailand | 1 | 1999 | 287 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3145 | 0.040 |
Why?
|
| Lactates | 1 | 2019 | 404 | 0.040 |
Why?
|
| Tyrosine | 1 | 2003 | 1440 | 0.040 |
Why?
|
| Quinolines | 2 | 1995 | 764 | 0.040 |
Why?
|
| Endopeptidases | 1 | 2002 | 774 | 0.040 |
Why?
|
| Infant | 6 | 2019 | 36152 | 0.040 |
Why?
|
| Citric Acid Cycle | 2 | 2013 | 231 | 0.040 |
Why?
|
| Thiophenes | 1 | 2003 | 569 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2003 | 1333 | 0.040 |
Why?
|
| Immunoglobulin M | 2 | 2015 | 1526 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1131 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1996 | 364 | 0.040 |
Why?
|
| Australia | 1 | 2021 | 1248 | 0.040 |
Why?
|
| Polyploidy | 1 | 1998 | 119 | 0.040 |
Why?
|
| Complement C1s | 1 | 2017 | 11 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2004 | 2635 | 0.040 |
Why?
|
| Cattle | 5 | 2006 | 3841 | 0.040 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2017 | 20 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1490 | 0.040 |
Why?
|
| Young Adult | 7 | 2013 | 59179 | 0.040 |
Why?
|
| Transferrin | 1 | 2018 | 283 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2019 | 704 | 0.040 |
Why?
|
| Cholesterol | 1 | 2006 | 2903 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2000 | 635 | 0.030 |
Why?
|
| Forecasting | 1 | 2006 | 2924 | 0.030 |
Why?
|
| Receptors, Transferrin | 1 | 2018 | 291 | 0.030 |
Why?
|
| Membranes | 1 | 2016 | 165 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1987 | 1301 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1865 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1997 | 411 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2003 | 3431 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2007 | 2722 | 0.030 |
Why?
|
| Poly A | 3 | 1985 | 181 | 0.030 |
Why?
|
| Histone Deacetylases | 2 | 2011 | 719 | 0.030 |
Why?
|
| Glycolysis | 1 | 2019 | 835 | 0.030 |
Why?
|
| Genotype | 3 | 2010 | 12978 | 0.030 |
Why?
|
| Animal Population Groups | 1 | 1995 | 12 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2012 | 522 | 0.030 |
Why?
|
| RNA, Helminth | 1 | 1995 | 60 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 1550 | 0.030 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2015 | 111 | 0.030 |
Why?
|
| Adenosine Triphosphate | 3 | 2004 | 1988 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2007 | 3045 | 0.030 |
Why?
|
| Endothelium, Vascular | 3 | 2005 | 4433 | 0.030 |
Why?
|
| Diphosphotransferases | 1 | 1994 | 1 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2001 | 2601 | 0.030 |
Why?
|
| Homeostasis | 2 | 2023 | 3321 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 265 | 0.030 |
Why?
|
| Oocytes | 2 | 1997 | 1166 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2001 | 1524 | 0.030 |
Why?
|
| Adult | 11 | 2022 | 220969 | 0.030 |
Why?
|
| Cations | 1 | 1995 | 238 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1827 | 0.030 |
Why?
|
| Peptide Fragments | 3 | 2001 | 5110 | 0.030 |
Why?
|
| Glucose-6-Phosphate | 1 | 2014 | 29 | 0.030 |
Why?
|
| Male | 14 | 2021 | 360358 | 0.030 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2013 | 5 | 0.030 |
Why?
|
| Phosphoenolpyruvate Carboxylase | 1 | 2013 | 8 | 0.030 |
Why?
|
| CHO Cells | 3 | 2007 | 1387 | 0.030 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2013 | 14 | 0.030 |
Why?
|
| Acetate-CoA Ligase | 1 | 2013 | 9 | 0.030 |
Why?
|
| Sodium | 1 | 2019 | 1588 | 0.030 |
Why?
|
| Nanostructures | 1 | 2019 | 551 | 0.030 |
Why?
|
| Staining and Labeling | 2 | 2010 | 1081 | 0.030 |
Why?
|
| Ion Transport | 1 | 1995 | 320 | 0.030 |
Why?
|
| Scattering, Small Angle | 1 | 2013 | 63 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2013 | 4269 | 0.030 |
Why?
|
| Antigens, CD | 2 | 2018 | 3998 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2015 | 381 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3548 | 0.030 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2013 | 63 | 0.030 |
Why?
|
| Cricetinae | 3 | 2007 | 2424 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18221 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1995 | 295 | 0.030 |
Why?
|
| Azides | 1 | 1993 | 118 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2015 | 6474 | 0.030 |
Why?
|
| Threonine | 1 | 1993 | 271 | 0.030 |
Why?
|
| Lipoproteins | 1 | 1998 | 879 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 421 | 0.030 |
Why?
|
| Sheep | 3 | 2004 | 1436 | 0.030 |
Why?
|
| Lipids | 1 | 2024 | 3332 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 778 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2013 | 153 | 0.030 |
Why?
|
| Heat-Shock Proteins | 2 | 2003 | 795 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 2014 | 392 | 0.030 |
Why?
|
| Schizosaccharomyces | 1 | 1994 | 237 | 0.030 |
Why?
|
| Pichia | 1 | 2012 | 49 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 1996 | 537 | 0.020 |
Why?
|
| Fluorenes | 1 | 2013 | 157 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 1997 | 1674 | 0.020 |
Why?
|
| Digestion | 1 | 1991 | 53 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12661 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 1991 | 111 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2012 | 190 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2012 | 428 | 0.020 |
Why?
|
| Euchromatin | 1 | 2011 | 54 | 0.020 |
Why?
|
| Cytokinesis | 1 | 2012 | 169 | 0.020 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 509 | 0.020 |
Why?
|
| RNA | 4 | 1985 | 2713 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6305 | 0.020 |
Why?
|
| Streptavidin | 1 | 2010 | 81 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2011 | 187 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2010 | 111 | 0.020 |
Why?
|
| Chromosome Deletion | 2 | 1992 | 1386 | 0.020 |
Why?
|
| Triglycerides | 1 | 1998 | 2459 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2012 | 725 | 0.020 |
Why?
|
| Serine | 1 | 1993 | 830 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2009 | 56 | 0.020 |
Why?
|
| Introns | 1 | 1992 | 968 | 0.020 |
Why?
|
| Mammals | 1 | 1995 | 1131 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2007 | 11514 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2326 | 0.020 |
Why?
|
| Immune Sera | 3 | 1984 | 605 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2002 | 3039 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 2012 | 534 | 0.020 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 90 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1347 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 2 | 2008 | 656 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2009 | 136 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 506 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 600 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 852 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 8166 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1995 | 2200 | 0.020 |
Why?
|
| Myosins | 1 | 2009 | 404 | 0.020 |
Why?
|
| Karyotyping | 1 | 1989 | 1171 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 294 | 0.020 |
Why?
|
| Algorithms | 2 | 2005 | 14018 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2011 | 487 | 0.020 |
Why?
|
| Enzymes | 1 | 2008 | 257 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2009 | 279 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2008 | 191 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2849 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1993 | 1606 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2014 | 1051 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 931 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2008 | 185 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2006 | 87 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 4 | 1990 | 550 | 0.020 |
Why?
|
| Blood Platelets | 1 | 1997 | 2478 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2006 | 70 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 1836 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3601 | 0.020 |
Why?
|
| Sequence Analysis | 2 | 1997 | 240 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1991 | 1070 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2006 | 316 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18381 | 0.020 |
Why?
|
| Retinal Pigments | 1 | 1985 | 83 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 814 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2001 | 1936 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2007 | 512 | 0.020 |
Why?
|
| Epigenomics | 1 | 2011 | 942 | 0.020 |
Why?
|
| Aminosalicylic Acid | 1 | 2004 | 20 | 0.020 |
Why?
|
| Sulfanilamides | 1 | 2004 | 14 | 0.020 |
Why?
|
| Artificial Gene Fusion | 1 | 2004 | 56 | 0.020 |
Why?
|
| Base Composition | 1 | 1985 | 290 | 0.020 |
Why?
|
| New Guinea | 1 | 1984 | 10 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 11069 | 0.010 |
Why?
|
| Dapsone | 1 | 2004 | 56 | 0.010 |
Why?
|
| Terpenes | 1 | 2004 | 96 | 0.010 |
Why?
|
| Rhodopsin | 1 | 1985 | 203 | 0.010 |
Why?
|
| Haplotypes | 1 | 2010 | 2713 | 0.010 |
Why?
|
| Coenzymes | 1 | 2004 | 102 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2004 | 219 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2013 | 2020 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1989 | 2340 | 0.010 |
Why?
|
| Disease Vectors | 1 | 2004 | 61 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 789 | 0.010 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2004 | 133 | 0.010 |
Why?
|
| Vinblastine | 2 | 1996 | 488 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2004 | 645 | 0.010 |
Why?
|
| Placenta | 2 | 2006 | 1709 | 0.010 |
Why?
|
| Neoplasms | 2 | 1996 | 22131 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 532 | 0.010 |
Why?
|
| Acyl Carrier Protein | 1 | 2003 | 24 | 0.010 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1983 | 62 | 0.010 |
Why?
|
| Ghana | 1 | 1984 | 315 | 0.010 |
Why?
|
| Asparagine | 1 | 2003 | 119 | 0.010 |
Why?
|
| Fluorescence | 1 | 2005 | 756 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2016 | 41457 | 0.010 |
Why?
|
| Pregnancy | 3 | 2015 | 29868 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7995 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 6807 | 0.010 |
Why?
|
| Genomic Library | 1 | 2001 | 189 | 0.010 |
Why?
|
| Fluorescent Dyes | 2 | 2002 | 1901 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2005 | 741 | 0.010 |
Why?
|
| Biophysical Phenomena | 1 | 2002 | 319 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 942 | 0.010 |
Why?
|
| Magnesium | 1 | 2004 | 804 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 6126 | 0.010 |
Why?
|
| Biophysics | 1 | 2002 | 379 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 397 | 0.010 |
Why?
|
| Antiprotozoal Agents | 1 | 2001 | 94 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 565 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26049 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 647 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26180 | 0.010 |
Why?
|
| Transformation, Genetic | 1 | 2000 | 192 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3419 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 64568 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2001 | 392 | 0.010 |
Why?
|
| Gelatin | 1 | 2001 | 220 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 1991 | 3607 | 0.010 |
Why?
|
| Gene Library | 1 | 2002 | 1055 | 0.010 |
Why?
|
| Methionine | 1 | 2001 | 572 | 0.010 |
Why?
|
| Dogs | 1 | 2004 | 3838 | 0.010 |
Why?
|
| Africa South of the Sahara | 1 | 2001 | 745 | 0.010 |
Why?
|
| Lysine | 1 | 2003 | 993 | 0.010 |
Why?
|
| Recurrence | 1 | 2010 | 8426 | 0.010 |
Why?
|
| Hemin | 1 | 1997 | 51 | 0.010 |
Why?
|
| Temperature | 1 | 2004 | 2223 | 0.010 |
Why?
|
| Middle Aged | 4 | 2013 | 220584 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2930 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 1128 | 0.010 |
Why?
|
| Prazosin | 1 | 1996 | 95 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22115 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 1471 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 1997 | 151 | 0.010 |
Why?
|
| Mitosis | 1 | 2002 | 1187 | 0.010 |
Why?
|
| Incidence | 1 | 2015 | 21337 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2007 | 5463 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1088 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 1985 | 1712 | 0.010 |
Why?
|
| Organizations | 1 | 1996 | 171 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1996 | 299 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 1141 | 0.010 |
Why?
|
| Pheromones | 1 | 1995 | 93 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 14648 | 0.010 |
Why?
|
| Primaquine | 1 | 1994 | 28 | 0.010 |
Why?
|
| Genes, Fungal | 1 | 1995 | 439 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 15908 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 460 | 0.010 |
Why?
|
| Colchicine | 1 | 1994 | 259 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1996 | 1415 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1994 | 458 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1995 | 907 | 0.010 |
Why?
|
| Chromatography | 1 | 1990 | 189 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1994 | 450 | 0.010 |
Why?
|
| Reproduction | 1 | 1995 | 645 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 4919 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 1031 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1994 | 963 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2007 | 10175 | 0.010 |
Why?
|
| Chromosome Inversion | 1 | 1989 | 120 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 39063 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58894 | 0.000 |
Why?
|
| Arrestin | 1 | 1987 | 30 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1994 | 2224 | 0.000 |
Why?
|
| Ticks | 1 | 1987 | 70 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2010 | 54360 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1983 | 76 | 0.000 |
Why?
|
| Cell Survival | 1 | 1994 | 5780 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 509 | 0.000 |
Why?
|
| beta-Galactosidase | 1 | 1983 | 574 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1985 | 2261 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1983 | 611 | 0.000 |
Why?
|
| Aged | 1 | 2013 | 169042 | 0.000 |
Why?
|
| Immunoassay | 1 | 1984 | 744 | 0.000 |
Why?
|
| Immunity | 1 | 1983 | 994 | 0.000 |
Why?
|
| Proteins | 1 | 1984 | 6030 | 0.000 |
Why?
|